Doctors Treated a Deadly Heart Rhythm With Help From a Digital Twin

Johns Hopkins researchers used patient-specific digital twin hearts to plan ventricular tachycardia ablation.

The FDA allowed the technology to guide treatment for 10 patients in the trial reported in NEJM.

Eight of ten patients were arrhythmia-free after more than a year, and most stopped anti-arrhythmia drugs.